+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Immunosuppressant Drugs Market (2020-2025), By Application, Product and Sales Channel and Geography and the Impact of Covid-19 with Ansoff Analysis

  • ID: 5137776
  • Report
  • November 2020
  • Region: Global
  • 165 Pages
  • Infogence Global Research
UP TO OFF
until Nov 30th 2021
The Global Immunosuppressant Drugs Market is Expected to Reach USD 1.3 Bn During 2019-2025 at CAGR of 4.8%

FEATURED COMPANIES

  • Abbvie Inc
  • Accord Healthcare Ltd
  • Allergan Plc
  • Astellas Pharma, Inc
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
Introduction

Immunosuppressant drugs are class of drugs that reduce or suppress the body’s immune system. The immunosuppressant drugs are mostly used during organ transplant procedures. During organ transplants, the body is expected to reject the transplanted organ such as Kidney, Liver, and Heart etc. The drugs are also used to treat diseases like Lupus, Psoriasis, Crohn’s Diseases and Arthritis. Increase in the number of organ transplants has given boost to the global immunosuppressant market.

Global Immunosuppressant Drugs Market is expected to reach USD 1.3 Bn during 2019-2025 at a CAGR of 4.8%.

The growth of the market is attributed to increase in the number of autoimmune diseases and increase in demand for organ transplantation. However, the market is hindered by side-effects of immunosuppressant drugs and stringent Government regulation.
The increasing demand from emerging economies and export of drugs and medicines have created opportunities the market.

Market Dynamics

Drivers
  • Increase in the number of Autoimmune Disorders
  • Increase in demand for Organ Transplantation
  • Rising prevalence of Chronic Disease.
Restraints
  • Side-effects of Immunosuppressant Drugs
  • Stringent Government Regulations
Opportunities
  • Demand from Emerging Economies
  • Export of drugs and medicines
Segments Covered
Calcineurin inhibitors drugs are expected to hold major share in Global Immunosuppressant Drugs Market. This is due to their wide applications in organ transplantation and treatment of autoimmune diseases.
By application, Global Immunosuppressant Drugs Market is classified under autoimmune disease treatment, Organ Transplant and other applications. Organ transplant segment holds the largest market share.
North America region has the largest market share in Global Immunosuppressant Drugs Market owing to increasing number of cases with autoimmune disease and increasing number of organ transplants. On the other hand, Asia Pacific region is expected to grow at a highest CAGR during the forecast period.
The Global Immunosuppressant Drugs Market is segmented based on Drug Class, Application, Distribution Channel, End User, and Geography.

Global Immunosuppressant Drugs Market, By Dg Class
  • Introduction
  • Calcineurin Inhibitors
  • Antiproliferative Agents
  • DmTOR Inhibitor
  • Steroids
  • Other Drugs Classes
Global Immunosuppressant Drugs Market, By Application
  • Autoimmune Disease
  • Organ Transplant
  • Other Applications
Global Immunosuppressant Drugs Market, By Distribution Channel
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Global Immunosuppressant Drugs Market, By End User
  • Organ Transplantation
  • Autoimmune Disorders
  • Others
Global Immunosuppressant Drugs Market, By Geography
  • North America
  • South America
  • Europe
  • Asia Pacific
  • Middle East and Africa
Company Profiles
Some of the companies covered in this report are Astellas Pharma, Sanofi, Bristol-Myers Squibb, Novartis, GSK, Allergan, Cipla, Mylan Laboratories etc.

IGR Competitive Quadrant
The report includes IGR Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share etc.

Lions: Represents companies with a strong foothold in the market, with the highest market share, large investments in technologies, new products.
Bulls: Companies that are medium in size competing with their USPs, growing companies with proven market share.
Rabbits: Small companies but growing rapidly, constantly improving their offerings in the market.
Tortoise: Companies which are slow in growth, having a long legacy and stable or negative in performance.

Why buy this report?
The report offers a comprehensive evaluation of the Global Immunosuppressant Drugs Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources and projections about market size. The projections are calculated using proven research methodologies.
The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys and observation of renowned personnel in the industry.
The report includes in-depth market analysis using Porter’s 5 force model and Ansoff Matrix. Impact of Covid-19 on the market is also featured in the report.
The report also contains the competitive analysis using IGR Competitive Quadrant, a Proprietary competitive positioning tool.

Report Highlights:
  • A complete analysis of the market including parent industry
  • Important market dynamics and trends
  • Market segmentation
  • Historical, current, and projected size of the market based on value and volume
  • Market shares and strategies of key players
  • Recommendations to companies for strengthening their foothold in the market
Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Abbvie Inc
  • Accord Healthcare Ltd
  • Allergan Plc
  • Astellas Pharma, Inc
  • Cipla Ltd
  • F. Hoffmann-La Roche Ltd
1. Report Description
1.1 Study Objectives
1.2 Market Definition
1.3 Currency
1.4 Years Considered
1.5 Language
1.6 Key Shareholders

2. Research Methodology
2.1 Research Process
2.2 Data Collection and Validation
2.2.1 Secondary Research
2.2.2 Primary Research
2.3 Market Size Estimation
2.4 Assumptions of the Study
2.5 Limitations of the Study

3. Executive Summary

4. Market Overview
4.1 Introduction
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Trends

5. Market Analysis
5.1 Porter’s Five Forces Analysis
5.2 Impact of COVID-19
5.3 Ansoff Matrix Analysis

6. Global Immunosuppressant Drugs Market, By Drug Class
6.1 Introduction
6.2 Calcineurin Inhibitors
6.3 Antiproliferative Agents
6.4 DmTOR Inhibitor
6.5 Steroids
6.6 Other Drugs Classes

7. Global Immunosuppressant Drugs Market, By Application
7.1 Autoimmune Disease
7.2 Organ Transplant
7.3 Other Applications

8. Global Immunosuppressant Drugs Market, By Distribution Channel
8.1 Hospital Pharmacies
8.2 Online Pharmacies
8.3 Retail Pharmacies

9. Global Immunosuppressant Drugs Market, By End User
9.1 Organ Transplantation
9.2 Autoimmune Disorders
9.3 Others

10. Global Immunosuppressant Drugs Market, By Geography
10.1 Introduction
10.2 North America
10.2.1 US
10.2.2 Canada
10.2.3 Mexico
10.3 South America
10.3.1 Brazil
10.3.2 Argentina
10.4 Europe
10.4.1 UK
10.4.2 France
10.4.3 Germany
10.4.4 Italy
10.4.5 Rest of Europe
10.5 Asia-Pacific
10.5.1 China
10.5.2 Japan
10.5.3 India
10.5.4 Australia
10.5.5 Rest of APAC
10.6 Middle East and Africa

11. Competitive Landscape
11.1 IGR Competitive Quadrant
11.2 Market Share Analysis
11.3 Competitive Scenario
11.3.1 Mergers & Acquisitions
11.3.2 Agreements, Collaborations, & Partnerships
11.3.3 New Product Launches & Enhancements
11.3.4 Investments & Fundings

12. Company Profiles
12.1 Astellas Pharma, Inc
12.2 Sanofi (Genzyme)
12.3 Bristol-Myers Squibb Company
12.4 Novartis AG
12.5 F. Hoffmann-La Roche Ltd
12.6 Pfizer Inc
12.7 GlaxoSmithKline plc
12.8 Allergan Plc
12.9 Accord Healthcare Ltd
12.10 Mylan Laboratories, Inc
12.11 Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
12.12 Cipla Ltd
12.13 Intas Pharmaceuticals Ltd (Accord Healthcare)
12.14 Veloxis Pharmaceuticals Inc
12.15 Abbvie Inc
12.16 Glenmark Phamaceutical, Inc.

13. Appendix
13.1 Questionnaire
Note: Product cover images may vary from those shown
  • Astellas Pharma, Inc
  • Sanofi (Genzyme)
  • Bristol-Myers Squibb Company
  • Novartis AG
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Allergan Plc
  • Accord Healthcare Ltd
  • Mylan Laboratories, Inc
  • Janssen Pharmaceuticals Inc (Johnson & Johnson Services Inc)
  • Cipla Ltd
  • Intas Pharmaceuticals Ltd (Accord Healthcare)
  • Veloxis Pharmaceuticals Inc
  • Abbvie Inc
  • Glenmark Pharmaceutical, Inc.
Note: Product cover images may vary from those shown

Loading
LOADING...

Adroll
adroll